Navigation Links
Stem cell leader awarded $2.3 million grant for Parkinson's
Date:2/4/2011

LA JOLLA, CA-The Salk Institute has been awarded a $2.3 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem cell based therapy for Parkinson's disease.

The research will concentrate on studying human induced pluripotent stem (iPS) cells derived from patients suffering from Parkinson's disease to replicate the disorder in the lab and investigate the role of inflammation in the cause and progression of the neurodegeneration typical of the disease.

Led by Fred H. Gage, Ph.D., a professor in the Salk's Laboratory of Genetics and holder of the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, the grant will fund a joint effort between Salk researchers, the team of Christopher Glass, Ph.D., a professor of Medicine and Cellular and Molecular Medicine at the University of California, San Diego, and international collaborators in Germany.

Parkinson's disease is a chronic, progressive neurological disease that usually occurs later in life and is linked to decreased dopamine production, the chemical messenger involved in communication between the brain and the muscles. The most common neurodegenerative movement disorder, Parkinson's disease is characterized by motor impairment such as slowness of movements, shaking and gait disturbances.

"Given that age is the most consistent risk factor for Parkinson's, and we have an aging population, it is of utmost importance that we unravel the cellular, molecular, and genetic causes of the highly specific cell death characteristic of the disease and find new therapies to limit the social, economic and emotional impact," said Gage.

Most studies to find better drugs to treat Parkinson's disease were done with mice and often failed when tested in patients. In the past, scientists had been limited to study the brains of people with Parkinson's disease via imaging technologies or postmortem brain tissues. Now, the ability to obtain iPS cells from patients' skin cells, which can be reprogrammed into neurons provides researchers with a model to study the pathological development of Parkinson's in a human system.

The main goal of the collaborative effort is to identify key molecular events involved in the early stages of the disease, which can be exploited as potential points of therapeutic intervention.

"This is an extremely exciting development - the ability to create stem cells from skin cells taken from patients with Parkinson's disease, then use those stem cells to create networks of neurons which can then be studied to give clues about the abnormal function of nerve cells in this debilitating disease - that would never have been conceived, let alone come to fruition, without the significant investment in regenerative medicine by CIRM," said Salk president William R. Brody, M.D., Ph.D.


'/>"/>

Contact: Kat Kearney
kkearney@salk.edu
858-453-410-01226
Salk Institute
Source:Eurekalert  

Related biology news :

1. Fred Kavli receives the Franklin Institutes 2011 Bower Award for Business Leadership
2. Oil spill symposium to convene scientists, media, policymakers and community leaders
3. Global Leaders Combine Forces to Provide Identity Security Documents for INTERPOL
4. European R&D leaders assembled in Tel Aviv will invest $70 million in joint R&D initiatives
5. Israeli Minister of Industry and Trade to address European R&D leaders in Tel Aviv
6. AACR congratulates William S. Dalton on 2010 Leadership in Personalized Medicine Award
7. Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards
8. VP, university leaders discuss ARRA impact on research
9. ‘Scientific leaders of the future’ gear up for important talks on Capitol Hill
10. Frost & Sullivan Award Underlines IrisGuards Product Quality Leadership
11. Pharma and food thought leaders set to converge in Amsterdam next April
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem cell leader awarded $2.3 million grant for Parkinson's
(Date:5/6/2017)... 2017 RAM Group , Singaporean ... breakthrough in biometric authentication based on a ... to perform biometric authentication. These new sensors are based ... by Ram Group and its partners. This sensor will ... chains and security. Ram Group is a next ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... on health-related quality of life, today announced its full advisory board. The board ... announced the promotion of James Crooks, PhD, former VP of Engineering, to Chief ...
(Date:7/20/2017)... ... July 20, 2017 , ... Crucial Data Solutions ... and study participants truly unified. TrialKit, a native mobile app, empowers investigators and ... research studies entirely on mobile devices. With TrialKit, clinical researchers can utilize Core ...
(Date:7/18/2017)... , ... July 18, 2017 , ... Blood centers traditionally ... across the region. Nationally, summer is a struggle for community blood centers as high ... San Antonio Chamber of Commerce is teaming up with the South ...
(Date:7/17/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced safety software company ... channel within the eHealth Solutions business segment to advance technology innovation across ...
Breaking Biology Technology: